This usually balances out within a week or two as your body adjusts
Semaglutide is now well known as the active ingredient in Novo Nordisks blockbuster type 2 diabetes drug Ozempic and weight-loss drug Wegovy, which were approved by the US Food and Drug Administration in 2017 and 2021, respectively
From oral formulations to wearable devices, these innovations are poised to revolutionize the way patients experience weight loss and wellness treatments
This multi-system impact explains why GLP-1 medications produce benefits beyond just weight loss
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Egbuna C., Awuchi C.G., Kushwaha G., Rudrapal M., Patrick-Iwuanyanwu K.C., Singh O., Odoh U.E., Khan J., Jeevanandam J., Kumarasamy S., et al